National Amyloidosis Centre, Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
Global longitudinal strain predicts survival and response in patients with systemic AL amyloidosis. analysis of 915 patients from the ALchemy prospective trial
